logo
Asston Pharmaceuticals disappoints with market debut, lists at 3% discount

Asston Pharmaceuticals disappoints with market debut, lists at 3% discount

Asston Pharmaceuticals IPO listing today: Shares of healthcare products supplier Asston Pharmaceuticals made a poor debut on the BSE SME platform on Wednesday, July 16, following the completion of its Initial Public Offering (IPO). The stock listed at ₹119 per share, reflecting a discount of ₹4 or 3.25 per cent over the IPO issue price of ₹123.
The Asston Pharmaceuticals IPO fell short of grey market expectations. Prior to the debut, its unlisted shares were trading at around ₹149 in the grey market, indicating a grey market premium (GMP) of ₹26 or approximately 21.14 per cent over the issue price, according to sources tracking unofficial market activity.
Asston Pharmaceuticals IPO details
The Asston Pharmaceuticals IPO comprised an entirely fresh issue of 2.24 million equity shares aggregating to ₹27.56 crore. The public offering was available for subscription from Wednesday, July 9, to Friday, July 11, at a price band of ₹115-123 per share, with a lot size of 1,000 shares.
The public issue received overwhelming demand from investors, getting oversubscribed by 173.53 times by the end of the subscription period, as per BSE data. The basis of allotment for Asston Pharmaceuticals IPO shares was finalised on Monday, July 14. The company has fixed the issue price at ₹123 per share.
Asston Pharmaceuticals will utilise the proceeds from its public issue to fund capital expenditure requirements, specifically for acquiring machinery for its manufacturing unit. A portion of the funds will also be allocated towards meeting the company's incremental working capital needs. Additionally, the proceeds will be used for the repayment and/or prepayment, either in part or in full, of certain outstanding borrowings. The remaining funds will be directed towards general corporate purposes.
About Asston Pharmaceuticals
Asston Pharmaceuticals specialises in exporting pharmaceuticals globally. The company offers a diverse range of products, including tablets, capsules, and syrups, across various therapeutic categories. Asston Pharmaceuticals is FDA-certified and complies with Quality Management System standards. The company's product portfolio includes medications for pain relief, infections, and vitamin deficiencies.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gujarat races ahead in IPO rush, tops Q1 listings and fundraising
Gujarat races ahead in IPO rush, tops Q1 listings and fundraising

Time of India

time3 hours ago

  • Time of India

Gujarat races ahead in IPO rush, tops Q1 listings and fundraising

Ahmedabad: Gujarat has surged ahead in the IPO race, topping the charts for the highest number of listings in the first quarter of FY26. A total of 14 companies from the state went public across the NSE and BSE platforms, collectively raising over Rs 3,495 crore, edging out heavyweights like Maharashtra and Delhi. Data from the National Stock Exchange (NSE) shows that nine Gujarat-based firms listed on both the mainboard and NSE Emerge, mobilised Rs 3,374 crore during April-June 2025. Maharashtra matched Gujarat in terms of the number of NSE listings but trailed slightly in proceeds at Rs 3,300 crore. Meanwhile, four companies from the NCT of Delhi raised the highest capital among states, mopping up Rs 3,657 crore. On the BSE SME platform, Gujarat again led in terms of company count, with five firms raising Rs 121.6 crore, nearly a third of the total SME IPOs during the quarter. "Among the companies listed in Q1, Gujarat led with the highest number of nine listings, reflecting the state's growing dominance in capital market activity," the NSE noted. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad Nationally, the sectoral breakdown of IPO activity reveals broad-based investor interest in sectors such as industrials, consumer discretionary, and energy. The industrial sector led with 13 companies raising Rs 2,176 crore, followed by consumer discretionary players, who raised a whopping Rs 9,033 crore from eight firms — the highest in terms of proceeds. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Why Seniors Are Snapping Up This TV Box, We Explain! Techno Mag Learn More Undo The energy sector saw just two listings, but raised a sizeable Rs 2,873 crore, putting it second in terms of capital raised. According to BSE SME data, 12 companies listed on the exchange's SME platform in Q1, raising a cumulative Rs 387.26 crore. Gujarat led with five listings, followed by Maharashtra, Haryana, Delhi and Uttar Pradesh. Vaibhav Shah, director at the Association of National Exchanges Members of India (ANMI), attributed the trend to strong governance and rising equity awareness among Gujarat's entrepreneurs. "Gujarat-based companies have seen rapid growth in recent years. Many are now eyeing aggressive expansion, and IPOs are the natural route. Strong governance frameworks and a solid understanding of equity markets are driving the surge in SME IPOs," he said. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !

Round trip to nowhere: Markets break a sweat, but not new ground
Round trip to nowhere: Markets break a sweat, but not new ground

Business Standard

time5 hours ago

  • Business Standard

Round trip to nowhere: Markets break a sweat, but not new ground

Markets moved. Wealth didn't. One year later, it's deja vu for investors Samie Modak Mumbai Listen to This Article After a roller-coaster year, the markets have ended up where they began. The benchmark Nifty 50 closed July at 24,768 — 183 points, or 0.73 per cent, below its July 2024 close of 24,951. Over the past 12 months, the advance/decline ratio for BSE-listed companies has been evenly split — six months of gains, six of losses. This fine balance between advancing and declining stocks underscores the difficulty investors have faced in locking in consistent returns. As a result, for many who entered the market through direct stocks or mutual funds, the outcome has been underwhelming.

PNB Housing Finance makes leadership appointments after MD & CEO exit
PNB Housing Finance makes leadership appointments after MD & CEO exit

Business Standard

time7 hours ago

  • Business Standard

PNB Housing Finance makes leadership appointments after MD & CEO exit

Following the resignation of its Managing Director and Chief Executive Officer (MD & CEO) Girish Kousgi, mortgage lender PNB Housing Finance has announced key appointments to its senior leadership. Jatul Anand, currently a function head, has been designated as Executive Director, and Valli Sekar as Chief Business Officer – Affordable Business, with effect from 2 August. Anand will be overall in charge of the Prime and Emerging Business vertical, including Sales, Credit, Product, and Collections. Sekar will lead the Affordable Business vertical, covering the same operational areas. On Friday, shares of PNB Housing Finance plummeted 18 per cent on the BSE after the lender announced that Kousgi had resigned to pursue opportunities outside the organisation. His resignation will take effect on 28 October, nearly a year before the scheduled end of his tenure. To reassure investors, the company said in a statement that the team would continue to pursue its goals of robust growth, asset quality, and healthy margins. The board, it added, will immediately begin the process of identifying a professional with proven expertise and industry experience to lead the company. Additionally, Kousgi will work with the board and senior management to ensure a smooth transition during this period. The company emphasised that its strategic priorities, business focus, and growth trajectory remain firmly intact, building on the strong foundations laid under Kousgi's leadership. In July 2025, Dilip Vaitheeswaran, Chief Sales Officer (Function Head), and Anujai Saxena, Business Head – Affordable Business, exited the organisation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store